Nov 11 (Reuters) - The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's (NVAX.O), opens new tab COVID-influenza ... shot and flu vaccine to drive ...

The clinical hold does not impact Novavax's COVID-19 vaccine. The big picture: Pfizer and BioNTech's effort to develop a ...

WASHINGTON — The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID ... FDA to resolve the clinical hold on the trial of its combination shot and the standalone ...

FDA places a clinical hold on Novavax's COVID-19-influenza vaccine trials due to a serious adverse event in a Phase 2 participant. Novavax's COVID-19 IND and European approval for its updated ...

Novavax said ... sell Novavax’s vaccine in most countries and use the COVID shot along with its own flu vaccines to develop a combination shot. Sanofi said the clinical hold has “nothing ...

Shares in Novavax fell by ... combination vaccine for COVID-19 and influenza as well as of its standalone flu shots, according to a securities filing. The FDA’s hold, which Novavax was informed ...

WASHINGTON — The Food and Drug Administration has lifted its clinical hold on ... combination shot and flu vaccine to drive future growth. Novavax's traditional protein-based COVID shot offers ...

US FDA Pauses Novavax's Trial of Combo COVID-Flu Shot on Safety Concerns By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration has put on hold a trial of Novavax's COVID-influenza and ...

Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza ...

The FDA has placed a clinical hold on Novavax’s Investigational New Drug (IND) application for its COVID-19-influenza combination (CIC) and stand-alone influenza vaccine candidates. The clinical ...

Oct 16 (Reuters) - The U.S. Food ... on hold a trial of Novavax's (NVAX.O), opens new tab COVID-influenza and its standalone flu vaccines after a participant who took the combination shot reported ...